[ Price : $8.95]
FDA grants Synta Pharmaceuticals a fast track designation for ganetespib, a heat shock protein 90 (Hsp90) inhibitor drug candidate...[ Price : $8.95]
FDA issues a draft guidance on developing bioanalytical method validation information for human and animal drugs.[ Price : $8.95]
Bristol-Myers Squibb says a Phase 3 trial of its Yervoy in treating advanced prostate cancer failed to meet its primary endpoint o...[ Price : $8.95]
United Therapeutics resubmits an NDA for treprostinil diolamine extended release tablets for treating pulmonary arterial hypertens...[ Price : $8.95]
OvaScience says it is suspending U.S. enrollment of its Augment in vitro fertilization egg enhancement product while it discusses ...[ Price : $8.95]
Federal Register Advance notice of proposed rulemaking: FDA extends the comment period to 11/22 on a 7/24 request for comments on ...[ Price : $8.95]
CDER director Janet Woodcock says the GDUFA Human Capital Team has hired and trained 234 new employees for GDUFA implementation.[ Price : $8.95]
CDER deputy director for clinical science Bob Temple says drug reviewers are becoming more aggressive with drug sponsors and their...